Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Published:2022-03-01 Issue:5 Volume:205 Page:550-562
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

McElroy Aoife N.¹,Invernizzi Rachele²^ORCID,Laskowska Joanna W.¹,O’Neill Andrew¹,Doroudian Mohammad³^ORCID,Moghoofei Mohsen⁴,Mostafaei Shayan⁵,Li Feng⁶,Przybylski Alexander A.⁶,O’Dwyer David N.⁷,Bowie Andrew G.⁸,Fallon Padraic G.¹⁹¹⁰,Maher Toby M.²¹¹^ORCID,Hogaboam Cory M.¹²,Molyneaux Philip L.²¹¹,Hirani Nik⁶¹³,Armstrong Michelle E.¹^ORCID,Donnelly Seamas C.¹¹⁴^ORCID

Affiliation:

1. School of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland;

2. National Heart and Lung Institute, Imperial College London, London, United Kingdom;

3. Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran;

4. Infectious Diseases Research Centre and

5. Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran;

6. MRC Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;

7. Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan;

8. School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, and

9. Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, Dublin, Ireland;

10. National Children's Research Centre, Our Lady's Children’s Hospital, Dublin, Ireland;

11. Royal Brompton Hospital, London, United Kingdom;

12. Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California;

13. Edinburgh Lung Fibrosis Clinic, Royal Infirmary Edinburgh, Edinburgh, United Kingdom; and

14. Department of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital, Tallaght, Dublin, Ireland

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.202010-3880OC

Reference50 articles.

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

2. Review Series--Inflammation & Fibrosis * Introduction

3. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

4. Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis

5. Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review;International Journal of Molecular Sciences;2024-08-16

2. Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease;Frontiers in Medicine;2024-04-03

3. Animal models of acute exacerbation of pulmonary fibrosis;Respiratory Research;2023-11-25

4. Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis;Biomedicines;2023-11-21

5. Study on potential differentially expressed genes in idiopathic pulmonary fibrosis by bioinformatics and next generation sequencing data analysis;2023-09-20